Emcure Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EMCURE PHARMS, and what generic and branded alternatives to EMCURE PHARMS drugs are available?
EMCURE PHARMS has two approved drugs.
There are three tentative approvals on EMCURE PHARMS drugs.
Summary for Emcure Pharms
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Emcure Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emcure Pharms Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202063-001 | Sep 11, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 200771-001 | Feb 14, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202063-002 | Sep 11, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 200771-002 | Feb 14, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
